1. Home
  2. CTSO vs RGS Comparison

CTSO vs RGS Comparison

Compare CTSO & RGS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CTSO
  • RGS
  • Stock Information
  • Founded
  • CTSO 1997
  • RGS 1922
  • Country
  • CTSO United States
  • RGS United States
  • Employees
  • CTSO N/A
  • RGS N/A
  • Industry
  • CTSO Medical/Dental Instruments
  • RGS Other Consumer Services
  • Sector
  • CTSO Health Care
  • RGS Consumer Discretionary
  • Exchange
  • CTSO Nasdaq
  • RGS Nasdaq
  • Market Cap
  • CTSO 61.7M
  • RGS 70.8M
  • IPO Year
  • CTSO N/A
  • RGS 1991
  • Fundamental
  • Price
  • CTSO $0.93
  • RGS $28.47
  • Analyst Decision
  • CTSO Buy
  • RGS
  • Analyst Count
  • CTSO 2
  • RGS 0
  • Target Price
  • CTSO $5.50
  • RGS N/A
  • AVG Volume (30 Days)
  • CTSO 98.2K
  • RGS 25.8K
  • Earning Date
  • CTSO 11-06-2025
  • RGS 11-05-2025
  • Dividend Yield
  • CTSO N/A
  • RGS N/A
  • EPS Growth
  • CTSO N/A
  • RGS 20.23
  • EPS
  • CTSO N/A
  • RGS 46.10
  • Revenue
  • CTSO $36,107,520.00
  • RGS $210,134,000.00
  • Revenue This Year
  • CTSO $11.93
  • RGS N/A
  • Revenue Next Year
  • CTSO $21.22
  • RGS N/A
  • P/E Ratio
  • CTSO N/A
  • RGS $0.65
  • Revenue Growth
  • CTSO 20.18
  • RGS 3.52
  • 52 Week Low
  • CTSO $0.71
  • RGS $15.00
  • 52 Week High
  • CTSO $1.61
  • RGS $30.29
  • Technical
  • Relative Strength Index (RSI)
  • CTSO 46.42
  • RGS 70.53
  • Support Level
  • CTSO $0.87
  • RGS $27.50
  • Resistance Level
  • CTSO $1.04
  • RGS $30.29
  • Average True Range (ATR)
  • CTSO 0.05
  • RGS 1.61
  • MACD
  • CTSO -0.00
  • RGS 0.42
  • Stochastic Oscillator
  • CTSO 38.45
  • RGS 81.10

About CTSO Cytosorbents Corporation

CytoSorbents Corp specializes in treating life-threatening conditions in intensive care and cardiac surgery using proprietary polymer adsorption technology. Its flagship product, CytoSorb, is approved in the EU as an extracorporeal cytokine absorber, aiming to reduce inflammation and prevent multiple organ failure in critical illnesses like sepsis and trauma. Revenue primarily comes from product sales in Germany, with additional income from grant agencies in the United States. The company operates through Direct sales and Distributors/strategic partners in United States, Germany and Other Countries. The company's product consists of Cytosorb, ECOS-300CY, VetResQ, HemoDefend, and DrugSorb-ATR.

About RGS Regis Corporation

Regis Corporation owns, franchises, and operates beauty salons in North America and the U.K., serving mainly price-conscious customers. Its salons, located mostly in strip malls, shopping centers, and Walmart stores, offer services like haircutting, styling, shampooing, conditioning, and hair coloring, along with hair care and beauty products. The company's primary brands include Supercuts, SmartStyle, and Cost Cutters. Regis generates the majority of its revenue from these mass-market locations and reports operations in two segments: franchise and company-owned, with services making up about 94% of company-owned salon sales.

Share on Social Networks: